Your Location：Home >News

Shanghai SE Pharm Co., Ltd
2021/07/08

Such as D-serine, D-tryp

Our important project Ibrutinib's key research data
2021/07/08

Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphoc
2021/07/08

Targeted therapies inclu

Our important project Ibrutinib's ROS introduction
2021/07/08

DRUG NEWS
2021/07/08

Launched by Sun Pharma i

DRUG NEWS OF OLAPARIB
2021/07/08

AstraZeneca and Merck &a

Links:
Copyright © 2024 Shanghai SE Pharm Co., Ltd